Announcements Trials
Browse Landscape

Phase

Phase 2 142Phase 3 65Phase 1/2 34Phase 1 29Phase 4 6Phase 2/3 5Phase NA 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 16Other hematologic neoplasm 6Genitourinary 2Sarcoma 1Gastrointestinal 1Dermatologic 1

Conditions

Prostatic Neoplasms 1Hormone Refractory Prostate Cancer 1

Interventions

Radiosurgery 73Magnetic Resonance Spectroscopy 48Standard of Care 41Radiotherapy 36Exercise 36Blood Specimen Collection 28Early Intervention, Educational 26Surveys and Questionnaires 24Multiparametric Magnetic Resonance Imaging 22Magnetic Resonance Imaging 21Brachytherapy 21Androgen Antagonists 20Methods 19Therapeutics 18Radiotherapy, Intensity-Modulated 18Interviews as Topic 18Cystectomy 16Educational Status 15Biopsy 15Psychiatric Rehabilitation 14Practice Guidelines as Topic 14Diet Therapy 14Sunitinib 12Specimen Handling 12Resistance Training 12gallium 68 PSMA-11 11Radiation 11Watchful Waiting 9Surgical Procedures, Operative 9Proton Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Prednisone × Genitourinary × Clear all
NCT01961843 2025-11-25

Abiraterone Acetate for Castrate Resistant Prostate Cancer

Massachusetts General Hospital

Phase NA Completed
40 enrolled
Genitourinary

Prostatic Neoplasms

NCT02208583 2014-08-05

Molecular Phenotype Changes and Personalized Treatment for CRPC

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
150 enrolled
Genitourinary

Hormone Refractory Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡